Pharma BD Deal Intelligence

AstraZeneca PLC / ZS Pharma Inc.

2015 · Acquisition/Merger · $2.7B · Complete

Announcement Sentiment

75

Strongly positive

Outcome Score

72

Largely worked — most objectives met.

AstraZeneca acquired ZS Pharma for $2.7B for hyperkalemia treatment.

Key facts

Announced Nov 06, 2015
Closed Dec 17, 2015
Deal value $2.7B
Deal type Acquisition/Merger
Therapeutic area Cardiovascular, Metabolic, Nephrology

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals